206 related articles for article (PubMed ID: 1525768)
1. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
[TBL] [Abstract][Full Text] [Related]
2. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
3. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
4. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
5. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
6. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
10. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
12. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
14. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
15. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
16. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
17. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
[TBL] [Abstract][Full Text] [Related]
18. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]